Joint Formulary & PAD

Haemophilia Factor - Haemophilia

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Red
Formulations :
  • Not Specified
Associated Icons :
BNF SPC
NHSE
Restrictions / Comments :

Documentation

  • No records returned.

PAD Profile

ChemicalSubstance :
Haemophilia Factor
Indication :
Haemophilia
Group Name :
Keywords :
human coagulation factors, haemophilia factor viii, haemophilia factor ix, haemophilia factor x, bleeding disorders, blood factors, clotting factors, efmoroctocog alfa, eftrenonacog alfa, albutrepenonacog alfa, nonacog gama, susoctocog alfa,
Brand Names Include :
Cogadex, Alprolix, Elocta, Obizur, Rixubis, Idelvion, Octaplex, NovoEight, Turoctocog alfa
Important Information :
NHS England - specialist centres only
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
0

Other Indications

Below are listed other indications that Haemophilia Factor is used to treat.

  • No records returned.

Committee Recommendations (1)

12 Sep 16 - Not Set
This product falls under the responsibility of NHS England Specialised Commissioning and should therefore not be prescribed in Primary Care